Commodore Capital’s Instil Bio TIL Stock Holding History

Commodore Capital’s Portfolio TIL Stock Details TIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-150,929	Closed	-$10.2M	–	40
2024 Q3	$10.2M	Buy	+150,929	New	+$3.55M	0.63%	30

Other funds holding TIL

CVV

Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Superstring Capital Management New York $158M AUM 418.32% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Commodore Capital's TIL Position: Q4 2024 in Review

Commodore Capital sold out of Instil Bio (TIL) in Q4 2024, closing a stake of 150,929 shares — an estimated $10.2M sold.

Commodore Capital first reported a position in TIL in Q3 2024 and held it in 1 quarter. The position peaked at $10.2M in Q3 2024. 39 funds tracked by Wall St. Rank hold TIL as of Q4 2024.

Commodore Capital reported no remaining Instil Bio position as of Q4 2024 after selling out during the quarter.
Commodore Capital sold 150,929 Instil Bio shares in Q4 2024, an estimated $10.2M.
Commodore Capital first reported a position in Instil Bio in Q3 2024 and held it in 1 quarter.
Commodore Capital's Instil Bio position peaked at $10.2M in Q3 2024.
39 funds tracked by Wall St. Rank held Instil Bio as of Q4 2024.

Based on Commodore Capital's 13F filing for Q4 2024, filed 14 Feb 2025.